InsidersTradesSigma
Track the 대웅제약 share price and the full insider trade history of the company, a publicly traded company based in South Korea. Shares are quoted on the KR market, under the authority of DART (FSS). Operating in the Health Care sector, 대웅제약 has logged 2 reports. Market capitalisation: €1,460.1bn. The latest transaction was reported on 27 March 2026 (Sale). Among the most active insiders: 대웅. The full history is accessible without an account.
Analysts rate 대웅제약 Buy (bullish), based on 9 analysts. Average price target: ₩207,778.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Daewoong Pharmaceutical 是一家韩国制药公司，专注于药物的开发和制造。该公司在 XKRX 上市。